Market Research Logo

Oral Controlled Release Drug Delivery Technology Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Oral Controlled Release Drug Delivery Technology Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Large-scale requirement of anti-hypertensive drugs and higher adoption of combination approaches drive the global oral controlled release drug delivery technology market

The increase in generic drug consumption is driven by rising access to healthcare facilities and is fuelling the need for faster availability of drugs in oral solid dosages. This in turn fuels the need for application of controlled release technology, which could increase the availability of the drugs in reduced dosages. Further, with many big drug makers establishing a local manufacturing presence across various regions, the adoption of controlled release technology is expected to witness a growing spiral in the coming years especially in countries such as Brazil, Argentina, Costa Rica and Mexico.

The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes. This helps in better pricing and rapid time to market for the otherwise unviable products in the short run. A higher adoption of combination approaches is expected to boost the global market for oral controlled release drug delivery technology.

Increasing approvals of modified and extended release oral dosage forms by PMDA is likely to drive the growth in revenue of the Japan oral controlled release drug delivery technology market. In the case of new approvals, high preference towards tablets and capsules has been observed, as formulation scientists find it easy to create formulations for clinical as well as therapeutic use. Moreover, when compared to western countries such as the U.S. and Germany, Japan offers greater variety in the choice of oral solid dosage forms due to increased accessibility to local formulations. Large-scale requirement of anti-hypertensive drugs are likely to boost the market growth to a great extent. The large-scale requirement of anti-hypertensive drugs is fuelling the need for more companies to set up plants deploying controlled release technologies. The requirement is more for technology adoption of OROS and SODAS. Indigenous development of pharmaceutical infrastructure is a very important factor expected to fuel revenue growth of the oral controlled release drug delivery technology market.

Diffusion and Dissolution are the most preferred controlled release systems, representing a lucrative market opportunity for manufacturers of oral controlled release drug delivery technologies

The Dissolution Controlled Release System segment dominated the global oral controlled release drug delivery technology market in terms of revenue in 2017, and the trend is projected to continue throughout the forecast period. Dissolution Controlled Release System is the most attractive segment, with an attractiveness index of 3.6 over the forecast period. This segment accounted for close to 45% value share in 2017 and is projected to hold about 50% share by 2027 end. The Others segment, which includes upcoming technologies such as nanotechnology and other advanced matrix technologies is also growing at an exponential rate in terms of revenue in 2017 and the trend is projected to sustain throughout the forecast period. The Others segment is the most attractive segment, with a market attractiveness index of 0.6 over the forecast period. Controlled Release is the most common strategy adopted by pharma giants across the globe to extend the product life cycle. Modified or controlled release formulations of pre-approved drugs are enjoying extended market exclusivity. The introduction of proprietary prescribed medicines in controlled release forms will help drive revenue growth of the global market. Other release mechanisms include enteric release, osmotically active release, effervescent and sublingual release. OROS (Johnson & Johnson and Alza Corporation) and SODAS (Elan Technologies) are the most commercialised technologies in the oral controlled release drug delivery technology market.


1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Oral Controlled Release Drug Delivery Technology Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Trends
3.4. Recent advancements in Oral Controlled Release Drug Delivery Technology
4. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
4.5.1. Diffusion Controlled Release System
4.5.2. Dissolution Controlled Release System
4.5.3. Osmotically Controlled Release System
4.5.4. Dissolution & Diffusion Controlled Release System
4.5.5. Ion Exchange Resins Controlled Release
4.5.6. Hydro-dynamically balanced drug delivery system
4.5.7. Others
4.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
4.6.1. Diffusion Controlled Release System
4.6.2. Dissolution Controlled Release System
4.6.3. Osmotically Controlled Release System
4.6.4. Dissolution & Diffusion Controlled Release System
4.6.5. Ion Exchange Resins Controlled Release
4.6.6. Hydro-dynamically balanced drug delivery system
4.6.7. Others
4.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
4.7.1. Solid Dosage Forms
4.7.2. Semisolid/Liquid/ Suspensions
4.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
4.8.1. Solid Dosage Forms
4.8.2. Semisolid/Liquid/ Suspension
4.9. Market Attractiveness Analysis
4.9.1. By Country
4.9.2. By Drug Release System
4.9.3. By Dosage Form
4.10.Key Representative Market Participants
4.11.Market Presence (Intensity Map)
4.12.Forecast Impact Factors
5. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
5.5.1. Diffusion Controlled Release System
5.5.2. Dissolution Controlled Release System
5.5.3. Osmotically Controlled Release System
5.5.4. Dissolution & Diffusion Controlled Release System
5.5.5. Ion Exchange Resins Controlled Release
5.5.6. Hydro-dynamically balanced drug delivery system
5.5.7. Others
5.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
5.6.1. Diffusion Controlled Release System
5.6.2. Dissolution Controlled Release System
5.6.3. Osmotically Controlled Release System
5.6.4. Dissolution & Diffusion Controlled Release System
5.6.5. Ion Exchange Resins Controlled Release
5.6.6. Hydro-dynamically balanced drug delivery system
5.6.7. Others
5.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
5.7.1. Solid Dosage Forms
5.7.2. Semisolid/Liquid/ Suspensions
5.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
5.8.1. Solid Dosage Forms
5.8.2. Semisolid/Liquid/ Suspension
5.9. Market Attractiveness Analysis
5.9.1. By Country
5.9.2. By Drug Release System
5.9.3. By Dosage Form
5.10.Key Representative Market Participants
5.11.Market Presence (Intensity Map)
5.12.Forecast Impact Factors
6. Western Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. Spain
6.3.5. U.K.
6.3.6. Nordic
6.3.7. Rest of Western Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Germany
6.4.2. Italy
6.4.3. France
6.4.4. Spain
6.4.5. U.K.
6.4.6. Nordic
6.4.7. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
6.5.1. Diffusion Controlled Release System
6.5.2. Dissolution Controlled Release System
6.5.3. Osmotically Controlled Release System
6.5.4. Dissolution & Diffusion Controlled Release System
6.5.5. Ion Exchange Resins Controlled Release
6.5.6. Hydro-dynamically balanced drug delivery system
6.5.7. Others
6.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
6.6.1. Diffusion Controlled Release System
6.6.2. Dissolution Controlled Release System
6.6.3. Osmotically Controlled Release System
6.6.4. Dissolution & Diffusion Controlled Release System
6.6.5. Ion Exchange Resins Controlled Release
6.6.6. Hydro-dynamically balanced drug delivery system
6.6.7. Others
6.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
6.7.1. Solid Dosage Forms
6.7.2. Semisolid/Liquid/ Suspensions
6.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
6.8.1. Solid Dosage Forms
6.8.2. Semisolid/Liquid/ Suspension
6.9. Market Attractiveness Analysis
6.9.1. By Country
6.9.2. By Drug Release System
6.9.3. By Dosage Form
6.10.Key Representative Market Participants
6.11.Market Presence (Intensity Map)
6.12.Forecast Impact Factors
7. Eastern Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
7.5.1. Diffusion Controlled Release System
7.5.2. Dissolution Controlled Release System
7.5.3. Osmotically Controlled Release System
7.5.4. Dissolution & Diffusion Controlled Release System
7.5.5. Ion Exchange Resins Controlled Release
7.5.6. Hydro-dynamically balanced drug delivery system
7.5.7. Others
7.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
7.6.1. Diffusion Controlled Release System
7.6.2. Dissolution Controlled Release System
7.6.3. Osmotically Controlled Release System
7.6.4. Dissolution & Diffusion Controlled Release System
7.6.5. Ion Exchange Resins Controlled Release
7.6.6. Hydro-dynamically balanced drug delivery system
7.6.7. Others
7.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
7.7.1. Solid Dosage Forms
7.7.2. Semisolid/Liquid/ Suspensions
7.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
7.8.1. Solid Dosage Forms
7.8.2. Semisolid/Liquid/ Suspension
7.9. Market Attractiveness Analysis
7.9.1. By Country
7.9.2. By Drug Release System
7.9.3. By Dosage Form
7.10.Key Representative Market Participants
7.11.Market Presence (Intensity Map)
7.12.Forecast Impact Factors
8. Asia Pacific excluding Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.3.1. China
8.3.2. India
8.3.3. ASEAN
8.3.4. Australia and New Zealand
8.3.5. Rest of APEJ
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. China
8.4.2. India
8.4.3. ASEAN
8.4.4. Australia and New Zealand
8.4.5. Rest of APEJ
8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
8.5.1. Diffusion Controlled Release System
8.5.2. Dissolution Controlled Release System
8.5.3. Osmotically Controlled Release System
8.5.4. Dissolution & Diffusion Controlled Release System
8.5.5. Ion Exchange Resins Controlled Release
8.5.6. Hydro-dynamically balanced drug delivery system
8.5.7. Others
8.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
8.6.1. Diffusion Controlled Release System
8.6.2. Dissolution Controlled Release System
8.6.3. Osmotically Controlled Release System
8.6.4. Dissolution & Diffusion Controlled Release System
8.6.5. Ion Exchange Resins Controlled Release
8.6.6. Hydro-dynamically balanced drug delivery system
8.6.7. Others
8.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
8.7.1. Solid Dosage Forms
8.7.2. Semisolid/Liquid/ Suspensions
8.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
8.8.1. Solid Dosage Forms
8.8.2. Semisolid/Liquid/ Suspension
8.9. Market Attractiveness Analysis
8.9.1. By Country
8.9.2. By Drug Release System
8.9.3. By Dosage Form
8.10.Key Representative Market Participants
8.11.Market Presence (Intensity Map)
8.12.Forecast Impact Factors
9. Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
9.3.1. Diffusion Controlled Release System
9.3.2. Dissolution Controlled Release System
9.3.3. Osmotically Controlled Release System
9.3.4. Dissolution & Diffusion Controlled Release System
9.3.5. Ion Exchange Resins Controlled Release
9.3.6. Hydro-dynamically balanced drug delivery system
9.3.7. Others
9.4. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
9.4.1. Diffusion Controlled Release System
9.4.2. Dissolution Controlled Release System
9.4.3. Osmotically Controlled Release System
9.4.4. Dissolution & Diffusion Controlled Release System
9.4.5. Ion Exchange Resins Controlled Release
9.4.6. Hydro-dynamically balanced drug delivery system
9.4.7. Others
9.5. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
9.5.1. Solid Dosage Forms
9.5.2. Semisolid/Liquid/ Suspensions
9.6. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
9.6.1. Solid Dosage Forms
9.6.2. Semisolid/Liquid/ Suspension
9.7. Market Attractiveness Analysis
9.7.1. By Drug Release System
9.7.2. By Dosage Form
9.8. Key Representative Market Participants
9.9. Market Presence (Intensity Map)
9.10.Forecast Impact Factors
10. Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
10.1.Introduction
10.2.Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
10.4.Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of MEA
10.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016
10.5.1. Diffusion Controlled Release System
10.5.2. Dissolution Controlled Release System
10.5.3. Osmotically Controlled Release System
10.5.4. Dissolution & Diffusion Controlled Release System
10.5.5. Ion Exchange Resins Controlled Release
10.5.6. Hydro-dynamically balanced drug delivery system
10.5.7. Others
10.6.Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027
10.6.1. Diffusion Controlled Release System
10.6.2. Dissolution Controlled Release System
10.6.3. Osmotically Controlled Release System
10.6.4. Dissolution & Diffusion Controlled Release System
10.6.5. Ion Exchange Resins Controlled Release
10.6.6. Hydro-dynamically balanced drug delivery system
10.6.7. Others
10.7.Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
10.7.1. Solid Dosage Forms
10.7.2. Semisolid/Liquid/ Suspensions
10.8.Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
10.8.1. Solid Dosage Forms
10.8.2. Semisolid/Liquid/ Suspension
10.9.Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Drug Release System
10.9.3. By Dosage Form
10.10. Key Representative Market Participants
10.11. Market Presence (Intensity Map)
10.12. Forecast Impact Factors
11. Forecast Factors: Relevance and Impact
12. Competition Landscape
12.1.Competition Dashboard
12.2.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
12.2.1. AstraZeneca Plc.
12.2.2. Bristol-Myers Squibb Company
12.2.3. Sun Pharmaceuticals Industries Ltd
12.2.4. Abbott Laboratories
12.2.5. Merck & Co. Inc.
12.2.6. Novartis AG
12.2.7. Pfizer Inc.
12.2.8. Mylan N.V.
12.2.9. Sanofi
12.2.10. F. Hoffman-La-Roche Ltd.
12.2.11. Johnson & Johnson Services, Inc.
12.2.12. Vectura Group plc.
12.2.13. GlaxoSmithKline plc.
13. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Region
13.1.Introduction/Key Findings
13.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
13.2.1. North America
13.2.2. Latin America
13.2.3. Western Europe
13.2.4. Eastern Europe
13.2.5. Asia Pacific excluding Japan
13.2.6. Japan
13.2.7. Middle East & Africa
13.3.Market Size (US$ Mn) Forecast By Region, 2017–2027
13.3.1. North America
13.3.2. Latin America
13.3.3. Western Europe
13.3.4. Eastern Europe
13.3.5. Asia Pacific excluding Japan
13.3.6. Japan
13.3.7. Middle East & Africa
13.4.Market Attractiveness Analysis By Region
14. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Release Systems Type
14.1.Introduction/Key Findings
14.2.Historical Market Size (US$ Mn) Trend Analysis By Drug Release Systems , 2012–2016
14.2.1. Diffusion Controlled Release System
14.2.2. Dissolution Controlled Release System
14.2.3. Osmotically Controlled Release System
14.2.4. Dissolution & Diffusion Controlled Release System
14.2.5. Ion Exchange Resins Controlled Release
14.2.6. Hydro-dynamically balanced drug delivery system
14.2.7. Others
14.3.Market Size (US$ Mn) Forecast By Drug Release Systems, 2017–2027
14.3.1. Diffusion Controlled Release System
14.3.2. Dissolution Controlled Release System
14.3.3. Osmotically Controlled Release System
14.3.4. Dissolution & Diffusion Controlled Release System
14.3.5. Ion Exchange Resins Controlled Release
14.3.6. Hydro-dynamically balanced drug delivery system
14.3.7. Others
14.4.Market Attractiveness Analysis By Drug Release Systems
15. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Dosage Form
15.1.Introduction/Key Findings
15.2.Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016
15.2.1. Solid Dosage Forms
15.2.2. Semisolid/Liquid/ Suspension
15.3.Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027
15.3.1. Solid Dosage Forms
15.3.2. Semisolid/Liquid/ Suspension
15.4.Market Attractiveness Analysis By Dosage
16. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
16.1.Market Size and Y-o-Y Growth
16.2.Absolute $ Opportunity
16.3.Market Value Chain
16.4.Forecast Impact Factors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report